U.S. Stock Futures Edge Up to End Choppy Week on Wall Street

10/16/2020 | 10:12am

By Joe Wallace

U.S. stock futures ticked up Friday as retail sales data beat expectations, signaling potential mild gains to end to a volatile week on Wall Street.

Futures tied to the S&P 500 edged up 0.4% after the broad stocks gauge fell for a third straight day Thursday. The benchmark is on track to eke out its most tepid one-week advance for this year. Contracts for the technology-heavy Nasdaq-100 edged up 0.6%.

Data showed U.S. retail sales rose for a fifth month in a row in September. Sales climbed 1.9%, the Commerce Department said, faster than the 0.7% analysts were expecting.

"They're really strong numbers," said Jane Foley, head of foreign-exchange strategy at Rabobank. Still, "there is a sense this could be the last hurrah." Consumer-spending growth is likely to slow in the coming months due to growing weakness in the labor market and delays to a fresh round of economic relief, she said.

Yields on 10-year Treasurys rose to 0.747%, from 0.730% Thursday. The WSJ Dollar Index, which tracks the U.S. currency against a basket of others, slipped 0.2%.

Stocks have been buffeted in recent days by spikes in coronavirus infection levels and uncertainty around the likelihood of a second batch of economic stimulus being delivered before Election Day. Investors say a new round of relief is needed to keep the U.S. economy in recovery mode.

"There are some pretty significant concerns that we're going to see a ramp-up in infections in the U.S.," said Ronald Temple, head of U.S. equity at Lazard Asset Management. "I am worried that could be a headwind between now and year-end."

The burst of infection could prompt authorities to bring in new curbs, Mr. Temple said, and is likely to make consumers more cautious. Many investors are overly bullish about the chances of a vaccine being developed and distributed, he said.

Pfizer said it could be ready to apply for emergency-use authorization of its vaccine by late November, the first time a leading Western vaccine developer provided such a specific timeline. Shares in the pharmaceutical giant rose around 1% before the bell in New York.

White House and Democratic negotiators agreed Thursday to include a national coronavirus-testing strategy in relief legislation. Many Republican lawmakers are wary of approving another bill approaching $2 trillion in size, but President Trump on Thursday insisted they will back him despite their current misgivings.

"They might get something together, but it's really surprising that it hasn't happened yet," said Jonas Goltermann, senior markets economist at Capital Economics.

Another factor weighing on stocks is concern about how quickly drugmakers will be able to come to market with an immunization shot, Mr. Goltermann added, pointing to the pause in trials of Johnson & Johnson's vaccine. "That's arguably even more important than the fiscal stimulus."

More than half a dozen states reported record numbers of new coronavirus cases Thursday, pushing the U.S.'s single-day total above 60,000 for the first time in over two months. Midwestern states including Ohio, Wisconsin and Michigan were particularly hard hit.

Consumer spending may falter over the winter if Washington doesn't deliver a new round of stimulus, according to Mr. Temple. "The longer this persists without that extra unemployment benefit the more likely we are to see evictions, mortgage delinquencies and other kinds of credit defaults," he said.

Other data indicate the economy is already losing momentum. New applications for unemployment benefits, a proxy for layoffs, last week rose to the highest level since late August.

In overseas markets, European stocks recouped some recent losses, pushing the Stoxx Europe 600 up 1%. Asian markets were mixed by the close of trading, with China's Shanghai Composite Index ticking up 0.1% and Japan's Nikkei 225 losing 0.4%.

Giving European stocks a lift, Thyssenkrupp jumped 11% after the German industrial conglomerate said it was examining a bid by Liberty Steel Group to acquire its steel operations. Fellow steelmakers ArcelorMittal and Voestalpine also advanced.

European luxury stocks gained ground after LVMH Moët Hennessy Louis Vuitton said strong growth at its biggest fashion brands buoyed revenue in the third quarter. Shares in the region's auto makers climbed after Daimler sounded an upbeat note for the rest of 2020. Shares of Man Group rose around 5% after the investment manager said funds under management grew in the third quarter.

Traders will also parse data in U.S. industrial production, due from the Federal Reserve at 9:15 a.m. ET, and a preliminary reading at 10 a.m. of the University of Michigan Consumer Sentiment Index for this month. Economists expect industrial output to have continued its recovery in September, though at a slower pace than earlier in the summer.

U.S. crude-oil futures fell 1% to $40.82 a barrel ahead of weekly data on the number of active oil rigs from Baker Hughes.

Write to Joe Wallace at Joe.Wallace@wsj.com

(END) Dow Jones Newswires

10-16-20 0911ET

Copier lien
Latest news about "Markets"
1h ago
1h ago
2h ago
13h ago
15h ago